Good Participatory Practice Guidelines for Trials of Emerging (And Re-emerging) Pathogens  that are Likely to Cause Severe Outbreaks in the Near Future and for Which Few or No Medical Countermeasures Exist

In 2016, the World Health Organization prepared these guidelines on Good Participatory Practice for Trials of Emerging Pathogens (GPP-EP). GPP-EP address how to engage community stakeholders and promote ethical standards throughout the research process. The guidelines are based on Good Participartory Practice originally developed by AVAC and UNAIDS for HIV prevention research.